ReviewBiogerontology2026
Decoding the complex nexus: the mechanistic interplay of hyperhomocysteinemia in brain aging and neurological disorders.
Review in Biogerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As ageing populations worldwide confront an increasing prevalence of neurological deficits, elucidating the underlying causes and associated factors has become paramount. The decline in age-related cellular processes precipitates neurodegeneration and cognitive decline, significantly impairing quality of life. Homocysteine (Hcy), a physiological amino acid resulting from protein catabolism, can lead to hyperhomocysteinemia (HHcy) when present at elevated levels. While the deleterious effects of high Hcy levels on arterial health and cardiovascular disease are well-documented, the connection between Hcy and brain diseases remains largely underexplored. Recent findings reveal that disruptions in Hcy metabolism, coupled with deficiencies in vitamin B12 along with folate can alter methylation as well as redox states, ultimately impacting calcium influx and contributing to the accumulation of amyloid and tau proteins. Severe undesired conditions like neuronal necrosis, and apoptosis may happen due to these biochemical signaling cascades. This paper aims to synthesize current knowledge regarding the potential role of HHcy in neurodegenerative diseases, drawing compelling connections among dietary methionine daily consumption, HHcy, oxidative stress, mitochondrial functioning, and accelerated epigenetic aging. By offering a comprehensive exploration of these interrelationships, we aspire to illuminate the critical need for further research in this domain, ultimately fostering innovative therapeutic strategies for eliminating the effect of HHcy upon neurological health.
Indexed as
Identifiers
42120802What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.